CphI & P-Mec India
-
The Year That Was
Express Pharma (May 15-31, 2017) EXPANDING ACCESS Express Pharma has always taken a keen interest in India’s progress in the public welfare. Ascertaining that commitment to public health, this...
-
Pharma industry witnesses 68 deals in October 2017
Deal value decreases to $7.1 billion when compared five months average of $10.6 billion
-
New diabetes therapeutics to steal ground from insulin therapies: GBI Research
Increased market diversification is expected due to patent expiries for major insulin products
-
FDA approves Roche drugs for rare types of blood, lung cancers
The drug is already approved for patients who have been treated with Pfizer's lung cancer drug Xalkori
-
Crohn’s Disease diagnosed incident cases set to increase in the 7MM to 2026
The burden of diagnosed Crohn’s Disease (CD) is expected to grow between 2016 and 2026 in the seven major markets
-
Flexion’s Zilretta poised to shakeup knee osteoarthritis marketplace
The company anticipates a steady stream of novel therapies to enter the OA marketplace over the next 10 years
-
Affluent market, medical tourism to steer best-in line drug delivery devices in India
Trends indicate that medical tourism will also bolster the demand for sophisticated devices
-
Novartis seeks European approval for cell therapy Kymriah
The immunotherapy Kymriah is a key element of Novartis’s efforts to bolster its portfolio of oncology drugs
-
GSK gets boost for early cancer hopes with breakthrough status
The decision by the Food and Drug Administration paves the way for a speedy regulatory review of the BCMA drug for multiple myeloma
-
Biotech firms race to recruit good bugs in war on cancer
Certain bacteria seem to help in cancer by priming immune cells and smoothing the path for immunotherapy drugs known as PD-1 drugs
-
Merck’s drug gets US FDA approval
The drug is expected to be available from December, was approved both as a tablet and an injection
-
Sandoz says new clinical data support two biosimilars
The trials shows the efficacy and safety of biosimilar adalimumab
-
Novartis posts eye drug data amid play for Eylea’s turf
The Basel-based drugmaker hopes this latest analysis lends RTH258 additional muscle when matched head-to-head with Eylea
-
J&J’s Stelara shows promise against lupus in study
J&J said the results were strong enough to advance Stelara into larger Phase III testing
-
‘We received an excellent reaction from the European market’
Suresh Pareek, MD, Ideal Cures, in an interaction with Express Pharma, talks about the uniqueness of INSTACOAT 4G, which was recently displayed at CPhI Worldwide
-
Risk-based monitoring: Gaining ground
Risk-based monitoring (RBM) adoption is building momentum as pharma companies and CROs are shifting focus and are developing strategies to develop processes. An insight by Dr Bina Naik, Chief...
-
Beyond just a filler – application of calcium phosphates in direct compression formulations
Daniel Zakowiecki, Marek Lachmann and Tobias Heß Chemische Fabrik Budenheim, in this article outlines the most important properties of various grades of calcium salts of orthophosphoric acid
-
Time limit for stroke treatment may be longer in selected patients
The patients, all of whom had an occlusion of the intracranial internal carotid or proximal middle cerebral artery, were treated at 26 centres in the...
-
Trial data suggests new typhoid shot could halve infection rate
The vaccine developed by Bharat Biotech could also be used safely in babies
-
Coating performance evaluation of INSTACOAT 4G using various spray guns
Suresh Pareek, MD, Ideal Cures and Sanjay Negi, DGM Film Coatings, Ideal Cures, give an insight the coating performance of IDEAL CURES revolutionary product INSTACOAT 4G with high solids...
-
‘We are able to make many advances in XRPD to address industry needs’
Dr Michael Caves, India Business Development Manager, Malvern Instruments, in an interaction with Express Pharma, talks about the benefits of XRPD systems and its usage for multiple applications
-
Coating performance evaluation of INSTACOAT 4G in a batch coater
Suresh Pareek, MD, Ideal Cures and Sanjay Negi, DGM Film Coatings, Ideal Cures, evaluates coating uniformity and appearance of tablets coated with Ideal Cures’ revolutionary product INSTACOAT 4G, a...
-
India is an important market for Shin-Etsu in the global business
Hiroshi Watanabe, GM, Shin-Etsu Chemical Company, Japan, Shungo Fujii, Sales Manager, Shin-Etsu Chemical Company, Japan and Nitin Bhusane, Director, Shin-Etsu Chemcial Tylose India, in an interaction with Express Pharma,...
-
NEOMACHINE MFG CO: A leader in automatic coating technology
KOLKATA-BASED NEOMACHINE MFG CO was started in 1973 with an objective of manufacturing quality pharmaceutical machinery
-
Growth will be driven by targeting non-traditional markets
Mitul Shah, CEO, LabGuard India, in an interaction with Express Pharma talks about LabGuard’s future growth prospects
-
Save time and protect data integrity with fingerprint authentication
Aditya Marfatia, Director, Electrolab and Dr Neelam Sayed, Application Scientist, Electrolab give an insight about how Electrolab with a technological collaboration has introduced a convenient 21 CFR part 11...
-
‘We are known for quick, prompt and reliable service in the market’
Dr Kiran Badgujar, Founder and Director, Mack Pharmatech, talks about Mack Pharmatech’s services to the pharma industry and its growth prospects in an interaction with Express Pharma
Sikkim Pharma Summit Special - September 2018
Express Pharma, a leading industry publication, has been tracking Sikkim’s potential to become as a pharma hub.
